Medullary thyroid carcinoma: The third most common thyroid cancer reviewed
- PMID: 22870127
- PMCID: PMC3412473
- DOI: 10.3892/ol.2010.223
Medullary thyroid carcinoma: The third most common thyroid cancer reviewed
Abstract
Medullary thyroid cancer is a type of thyroid cancer of neuroendocrine origin. It occurs in hereditary and sporadic forms, and its aggressive behavior is associated with the clinical presentation and type of RET mutation. Total thyroidectomy remains the ideal choice of treatment. Early diagnosis and treatment are the fundamental for a 100% cure rate. In this study, we present our experience of 3 cases, along with a complete review of the literature derived from a Pubmed Database search.
Figures



References
-
- American Cancer Society. Cancer Facts and Figures. Atlanta, Ga: American Cancer Society; 2009.
-
- National Cancer Institute. SEER Incidence: Thyroid Cancer. Bethesda, MD: 2004.
-
- Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995. Cancer. 1998;83:2638–2648. - PubMed
-
- Engelbach M, Gorges R, Forst T, et al. Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements. J Clin Endocrinol Metab. 2000;85:1890. - PubMed
-
- Safioleas M, Stamatakos M, Karampali E, Rompoti N, Mouzopoulos G, Lygidakis N. Diagnosis and treatment aspects of medullary thyroid carcinoma. Chirurgia. 2006;101:121–126. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources